If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

  • There is currently no data for KBT

PDMR Announcement

12 Nov 2020 07:00

RNS Number : 0495F
K3 Business Technology Group PLC
12 November 2020
 

AIM: KBT

 

K3 Business Technology Group plc

("K3", "Company" or "Group")

PDMR Announcement

K3 Business Technology Group plc received notification on 10 November 2020 from Kestrel Partners LLP ("Kestrel") that on 10 November 2020 it acquired, on behalf of its discretionary clients, 68,000 ordinary shares of 25p each ("Shares") in the Company at a price of £1.147794 per share. In addition, on the 03 November 2020, Kestrel transferred in the market 39,740 ordinary shares at a price of £0.96 per share between accounts held by its discretionary clients. The notification also included the matters set out below.

Mr Scott, a non-executive director of K3, is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in K3 Business Technology Group plc.

Following these transactions, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 7,895,241 Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest hold 2,525,950 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 10,421,191 Shares in the Company, which represents 24.27% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

7,893,741

18.38%

Indirect

JIM Nominees Limited

415,981

0.97%

Indirect

Bank of New York Nominees Ltd

2,071,659

4.83%

Indirect

Bank of New York Nominees Ltd

36,810

0.09%

 

For further information contact:

K3 Business Technology Group plc

+44 (0) 161 876 4498

Adalsteinn Valdimarsson, CEO

 

Rob Price, CFO

 

 

 

finnCap Ltd

+44 (0) 207 220 0500

Nominated Adviser and Broker

 

Julian Blunt/James Thompson (Corporate finance)

 

Richard Chambers (Corporate Broking)

 

 

 

 

 

 

 

 

 

    

 

 

 

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP ('Kestrel')

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Oliver Rupert Andrew Scott (non-executive director of K3 Business Technology Group plc and Partner in Kestrel)

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

K3 Business Technology Group plc

b)

 

LEI

 

 

213800QOJ9OF2AV81748

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

25p Ordinary Shares

 

 

 

ISIN: GB00B00P6061

 

b)

 

Nature of the transaction

 

 

Purchase and Transfer 

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

£1.147794

 

68,000 Shares - Purchase

 

£0.95

 

39,740 Shares -

Transfer

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

Total 68,000 Shares @ £1.147794.

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

03/11/2020 - Transfer

10/11/2020 - Purchase

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBIBDBLXBDGGB
Date   Source Headline
1st Apr 20207:00 amRNSLoan Funding Secured and Update on Subsidiary
24th Mar 20207:00 amRNSDelay to Final Results
21st Feb 202011:28 amRNSHolding(s) in Company
18th Feb 20203:10 pmRNSDirector/PDMR Shareholding
17th Feb 202012:32 pmRNSBoard Appointment
6th Feb 20204:13 pmRNSBoard Changes
28th Oct 20196:15 pmRNSPDMR Announcement
24th Oct 20192:09 pmRNSDirector/PDMR Shareholding
22nd Oct 20192:00 pmRNSPrice Monitoring Extension
22nd Oct 20197:00 amRNSTrading update
12th Jul 20194:41 pmRNSPDMR Announcement
9th Jul 20197:00 amRNSInterim Results
18th Jun 20197:00 amRNSTrading Update
23rd May 20198:48 amRNSPDMR Announcement
22nd May 20192:05 pmRNSResult of AGM
19th Mar 20197:00 amRNSFinal Results
8th Feb 20192:42 pmRNSPDMR Dealings
22nd Jan 20191:06 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSTrading Update
29th Oct 20183:05 pmRNSHolding(s) in Company
20th Aug 20186:15 pmRNSHolding(s) in Company
9th Jul 20187:00 amRNSInterim Results
13th Jun 201810:44 amRNSHolding(s) in Company
11th Jun 20187:00 amRNSContracts Wins
7th Jun 20187:00 amRNSCapital Markets Afternoon & Notice of Results
30th May 201811:02 amRNSResult of AGM
30th May 20187:00 amRNSAGM Statement
6th Apr 20183:40 pmRNSHolding(s) in Company
5th Apr 20184:36 pmRNSPDMR Dealings
27th Mar 20187:00 amRNSFinal Results (17 months)
5th Mar 20183:48 pmRNSHolding(s) in Company
5th Jan 20189:50 amRNSHolding(s) in Company
27th Dec 20172:19 pmRNSDirector/PDMR Shareholding
12th Dec 20177:00 amRNSTrading Update
27th Sep 20177:00 amRNSSecond Interim Results
26th Sep 201711:52 amRNSHolding(s) in Company
18th Sep 201711:17 amRNSHolding(s) in Company
8th Aug 20173:55 pmRNSHolding(s) in Company
6th Jul 20175:25 pmRNSHolding(s) in Company
6th Jul 201710:48 amRNSPDMR Shareholding
6th Jul 20179:05 amRNSHolding(s) in Company
5th Jul 20171:17 pmRNSHolding(s) in Company
4th Jul 201711:41 amRNSReplacement:Result of General Meeting
4th Jul 201711:11 amRNSSIP Announcement
4th Jul 201711:06 amRNSResult of General Meeting
4th Jul 201710:36 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSSigning of Facility Amendment Agreement
30th Jun 20177:00 amRNSResult of Open Offer
12th Jun 201712:58 pmRNSResults of Proposed Placing
12th Jun 20177:00 amRNSFundraising & Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.